Enavate Sciences GP, LLC - 11 Sep 2025 SCHEDULE 13D/A Report for CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share (CAMP)

Filing Manager
Enavate Sciences GP, LLC
Reporting Manager
Enavate Sciences GP, LLC
Security
CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share
Symbol
CAMP
Shares outstanding
46,738,296 shares
Disclosed Ownership
3,785,802 shares
Ownership
8.1%
Form type
SCHEDULE 13D/A
Filing time
15 Sep 2025, 19:08:08 UTC
Date of event
11 Sep 2025
Next filing
23 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Enavate Sciences GP, LLC disclosed 8.1% ownership in CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share (CAMP) on 11 Sep 2025."

Quick Takeaways

  • Enavate Sciences GP, LLC filed SCHEDULE 13D/A for CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share (CAMP).
  • Disclosed ownership: 8.1%.
  • Date of event: 11 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 Sep 2025, 19:08.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Enavate Sciences GP, LLC 8.1% 3,785,802 0 3,785,802 /s/ James P. Boylan By James P. Boylan, Manager 0001953107
Everest Aggregator, LP 8.1% 3,785,802 0 3,785,802 /s/ James P. Boylan By: Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager 0002040426

Sponsored